Gatifloxacin versus ceftriaxone for uncomplicated enteric fever in Nepal: an open-label, two-centre, randomised controlled trial.
Because treatment with third-generation cephalosporins is associated with slow clinical improvement and high relapse burden for enteric fever, whereas the fluoroquinolone gatifloxacin is associated with rapid fever clearance and low relapse burden, we postulated that gatifloxacin would be superior t...
Hauptverfasser: | Arjyal, A, Basnyat, B, Nhan, H, Koirala, S, Giri, A, Joshi, N, Shakya, M, Pathak, K, Mahat, S, Prajapati, S, Adhikari, N, Thapa, R, Merson, L, Gajurel, D, Lamsal, K, Lamsal, D, Yadav, B, Shah, G, Shrestha, P, Dongol, S, Karkey, A, Thompson, C, Thieu, N, Thanh, D, Baker, S, Thwaites, G, Wolbers, M, Dolecek, C |
---|---|
Format: | Journal article |
Sprache: | English |
Veröffentlicht: |
Lancet
2016
|
Ähnliche Einträge
Ähnliche Einträge
-
Gatifloxacin versus chloramphenicol for uncomplicated enteric fever: an open-label, randomised, controlled trial.
von: Arjyal, A, et al.
Veröffentlicht: (2011) -
Gatifloxacin versus ofloxacin for the treatment of uncomplicated enteric fever in Nepal: an open-label, randomized, controlled trial
von: Koirala, S, et al.
Veröffentlicht: (2013) -
Gatifloxacin versus ofloxacin for the treatment of uncomplicated enteric fever in Nepal: an open-label, randomized, controlled trial.
von: Samir Koirala, et al.
Veröffentlicht: (2013-01-01) -
An Open Randomized Comparison of Gatifloxacin versus Cefixime for the Treatment of Uncomplicated Enteric Fever
von: Pandit, A, et al.
Veröffentlicht: (2007) -
An open randomized comparison of gatifloxacin versus cefixime for the treatment of uncomplicated enteric fever.
von: Pandit, A, et al.
Veröffentlicht: (2007)